resources

Erectile Dysfunction: A Complete Guide to Causes, Risk Factors, and Evaluation

Erectile dysfunction stems from complex vascular, neurological, and hormonal factors that clinicians evaluate through targeted physical exams and essential metabolic laboratory tests.

Erectile Dysfunction: A Complete Guide to Causes, Risk Factors, and Evaluation
Share
PinterestFacebookLinkedInRedditTelegramX (Twitter)
October 2, 2026
Testosterone, Body & Sexual Performance

Erectile dysfunction is not a disease in itself. It is a clinical symptom that indicates an underlying disruption in vascular, neurological, hormonal, or psychological systems. It is not an inevitable consequence of aging, nor is it simply a personal failure of willpower.

This guide examines the biological mechanisms behind erections, the overlapping conditions that impair them, and the clinical pathways used to evaluate persistent symptoms. By understanding how blood vessels, nerves, hormones, and daily health habits interact, men can approach medical evaluations with clarity and realistic expectations.

Medical Disclaimer

This article is for educational and informational purposes only. It does not constitute personal medical advice, formal diagnosis, or individualized treatment plans. Always consult a qualified physician or urologist regarding any persistent sexual health concerns or before making changes to prescribed medications.

Key Takeaways

  • Erectile dysfunction (ED) is defined as the persistent or recurrent inability to attain or maintain an erection sufficient for satisfactory sexual activity.
  • Occasional erectile difficulties are common and often resolve without medical intervention. Persistent difficulties warrant a formal medical evaluation.
  • Penile arteries are small, meaning vascular changes often appear in erectile tissue before causing noticeable symptoms in the coronary arteries.
  • Testosterone plays an important role in libido and erectile physiology, but low testosterone is rarely the sole cause of erectile dysfunction.
  • Multiple factors often coexist, including vascular disease, metabolic changes, prescription side effects, psychological stress, and sleep disorders.
  • Diagnostic evaluations prioritize comprehensive medical histories, focused physical examinations, and baseline laboratory panels over aggressive testing.

What Is Erectile Dysfunction and How Is It Defined?

Clinicians define erectile dysfunction as the consistent or recurrent difficulty in achieving or sustaining an erection adequate for sexual intercourse. According to clinical guidance from the American Urological Association (AUA) and the European Association of Urology (EAU), an occasional episode of difficulty does not meet the threshold for a clinical condition. True erectile dysfunction involves a persistent pattern that causes personal distress or relationship strain over several months.

An erection requires an intricate cascade of events. Sexual arousal begins in the brain, sending electrical signals down the spinal cord to the pelvic nerves. These nerve endings release nitric oxide, which stimulates smooth muscle relaxation in the corpora cavernosa of the penis. As these smooth muscle tissues relax, the cavernous arteries expand, allowing arterial blood to fill the spongy erectile chambers. As blood volume expands, the surrounding fibrous sheath (the tunica albuginea) compresses the small veins that normally drain the penis. This process, known as the veno-occlusive mechanism, traps blood under pressure to maintain rigidity.

When any part of this coordinated sequence breaks down, erectile quality suffers. Clinicians evaluate this symptom along several distinct axes:

  • Difficulty initiating an erection versus difficulty maintaining rigidity until completion.
  • Partial firmness that prevents penetration versus a complete absence of tumescence.
  • Situational occurrence, such as achieving firm erections during masturbation or sleep but struggling with a partner.
  • Generalized occurrence, where erectile difficulties happen across all sexual and non-sexual contexts.
  • Co-occurring changes in sexual desire, ejaculatory control, orgasm intensity, or penile sensation.

To standardize symptom assessment, urologists frequently use validated screening tools such as the International Index of Erectile Function (IIEF). This questionnaire evaluates erectile confidence, penetration frequency, maintenance capacity, and overall sexual satisfaction. Using standardized instruments helps clinicians establish a baseline severity score and measure changes over time during treatment.

Why Is Erectile Dysfunction Considered a Vascular Warning Sign?

The vascular network supplying the penis is sensitive to systemic circulatory health. The cavernous arteries that supply the erectile chambers measure roughly 1 to 2 millimeters in diameter. In contrast, the coronary arteries supplying the heart measure approximately 3 to 4 millimeters, and the carotid arteries measure 5 to 7 millimeters.

Because penile arteries are so narrow, they often show the effects of endothelial damage and arterial plaque buildup earlier than larger vessels. Endothelial dysfunction occurs when the delicate inner lining of blood vessels loses its ability to produce adequate nitric oxide. Without nitric oxide, blood vessels cannot dilate efficiently in response to sexual arousal. Atherosclerosis, or the accumulation of fatty plaques, further restricts arterial diameter and limits the volume of blood entering the erectile chambers.

Research highlighted in the Princeton IV Consensus Recommendations underscores that erectile dysfunction can serve as an early clinical marker for cardiovascular disease. In many men with underlying vascular impairment, erectile difficulties appear two to three years before major cardiovascular events like angina or myocardial infarction. Major urological guidelines, including those from the AUA and EAU, recommend treating vasculogenic erectile dysfunction as a cardiovascular risk factor.

For men presenting with gradual, painless erectile decline alongside cardiovascular risk factors, clinicians often calculate a 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk score. If a man between the ages of 40 and 60 has an intermediate or uncertain cardiovascular risk profile, advanced cardiometabolic evaluations like coronary artery calcium (CAC) scoring may be considered. A comprehensive sexual health assessment serves as an important window into total circulatory health. You can learn more about general circulatory connections by reading our lifestyle and cardiovascular support resources.

What Are the Major Physical, Neurologic, and Structural Causes?

Erectile function relies on intact nerves, healthy vascular tissue, and normal penile anatomy. When physical illness impairs any of these components, erectile capacity declines.

Vascular and Endothelial Conditions

Vascular disease represents the most common physical contributor to erectile dysfunction in older adults. Chronic hypertension forces arterial walls to thicken and stiffen, reducing their ability to widen during sexual stimulation. Dyslipidemia, characterized by high low-density lipoprotein (LDL) cholesterol or elevated triglycerides, accelerates the formation of atherosclerotic plaques inside the internal pudendal and cavernous arteries.

Diabetes mellitus exerts a particularly severe impact on the vascular system. Prolonged hyperglycemia damages both the microvasculature supplying blood to the nerves and the endothelial lining of the penile arteries. Men with long-standing or poorly controlled diabetes frequently experience erectile difficulties at earlier ages than men without metabolic disorders.

Neurological Impairments

Erections require uninterrupted communication between the central nervous system and peripheral pelvic nerves. Neurological conditions can disrupt these neural pathways at the brain, spinal cord, or local nerve level:

  • Central nervous system disorders: Conditions such as stroke, Parkinson disease, and multiple sclerosis can interrupt the brain's ability to initiate sexual arousal signals.
  • Spinal cord trauma: Injuries or compressive disc herniations in the lumbar or sacral spine can block the reflex arcs responsible for physical erections.
  • Peripheral neuropathies: Chronic diabetes or heavy alcohol exposure can damage peripheral autonomic nerves, preventing the release of neurotransmitters in erectile tissue.
  • Pelvic nerve trauma: Surgical procedures involving the prostate, bladder, rectum, or colon can stretch or sever the delicate cavernous nerve bundles running along the prostatic capsule.

Structural and Anatomical Disorders

Structural abnormalities in the penis can physically prevent normal rigidity or make intercourse uncomfortable. Peyronie disease is an acquired condition characterized by the formation of fibrous collagen plaques within the tunica albuginea. These inelastic plaques prevent the affected area from stretching as blood fills the penis, causing curvature, narrowing, or indentation during an erection.

Pelvic trauma, including pelvic fractures sustained in motor vehicle accidents or direct straddle injuries, can rupture the cavernous arteries or tear the tunica albuginea. In some cases, high-impact trauma leads to high-flow priapism or permanent vascular insufficiency that requires specialized surgical reconstruction.

How Do Prescription Medications and Substances Affect Erectile Function?

Prescription medications, over-the-counter products, and recreational substances are common contributors to sexual difficulties. Many medications alter blood pressure, interfere with central nervous system signaling, or disrupt circulating hormone balances.

When evaluating erectile concerns, clinicians conduct a thorough medication review to identify potential pharmacological contributors:

  • Antihypertensive agents: Thiazide diuretics and older beta-blockers can lower arterial pressure within the pelvis and interfere with smooth muscle relaxation. Newer blood pressure agents, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), have a lower likelihood of impairing erectile function.
  • Psychotropic medications: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) increase central serotonin availability. While beneficial for mood disorders, elevated serotonin can inhibit sexual arousal, blunt genital sensation, and delay ejaculation. Tricyclic antidepressants and first-generation antipsychotics also exhibit anticholinergic and anti-adrenergic properties that impair erectile response.
  • Hormonal therapies: Anti-androgens used in the treatment of benign prostatic hyperplasia (such as 5-alpha reductase inhibitors like finasteride and dutasteride) or prostate cancer therapies (such as GnRH agonists) lower circulating active androgens, which can decrease libido and erectile quality.
  • Opioid analgesics: Long-term opioid use suppresses the hypothalamic-pituitary-gonadal axis, leading to secondary hypogonadism, diminished sexual interest, and erectile difficulties.
  • Recreational substances: Chronic, heavy alcohol consumption impairs central nervous system reflex pathways, damages peripheral nerves, and disrupts hepatic estrogen clearance. Chronic tobacco and nicotine exposure directly constricts peripheral arterioles and accelerates endothelial damage.

Patients should never discontinue or modify prescribed medications without direct clinical guidance. If a specific medication is suspected of contributing to erectile difficulties, physicians can often adjust dosages or transition patients to alternative therapeutic classes.

What Role Do Hormones and Endocrine Biomarkers Play?

Hormones regulate sexual desire, penile tissue responsiveness, and general metabolic vitality. However, hormonal imbalances are rarely the single cause of erectile dysfunction. Instead, endocrine disorders typically interact with underlying vascular or psychological conditions.

Understanding foundational male hormone biology helps clarify why endocrine testing is an essential part of an ED evaluation. For an introduction to these concepts, consult our guide to understanding foundational male hormone biology.

Total and Free Testosterone

Testosterone is the primary male androgen produced by the Leydig cells of the testes under the stimulation of luteinizing hormone (LH). Testosterone supports central sexual desire (libido), mood, energy, and the maintenance of healthy smooth muscle tissue within the penis.

The AUA defines testosterone deficiency as a total testosterone level below 300 ng/dL confirmed on two separate morning blood samples, accompanied by characteristic clinical symptoms. While low testosterone frequently blunts libido and reduces the frequency of spontaneous morning erections, it does not always prevent a man from achieving an erection during physical stimulation. Conversely, normalizing testosterone levels in men with severe underlying vascular damage rarely resolves erectile dysfunction on its own.

Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH)

When a morning blood test indicates low total testosterone, clinicians measure gonadotropins to determine the origin of the deficiency:

  • Primary hypogonadism: Elevated LH and FSH levels indicate that the pituitary gland is sending strong signals, but the testes are failing to produce adequate testosterone.
  • Secondary hypogonadism: Low or inappropriately normal LH and FSH levels indicate that the issue resides in the hypothalamus or pituitary gland, failing to stimulate testicular production.

Prolactin

Prolactin is a hormone secreted by the anterior pituitary gland. Markedly elevated prolactin levels (hyperprolactinemia) can suppress the secretion of gonadotropin-releasing hormone (GnRH), driving down LH and testosterone levels. Hyperprolactinemia can also directly suppress central libido. Evaluating prolactin is particularly important when low testosterone is accompanied by unexplained headaches, visual disturbances, or severe loss of sexual desire.

Metabolic Biomarkers: Fasting Glucose, HbA1c, and Lipids

Because erectile dysfunction frequently reflects systemic metabolic health, clinicians routinely evaluate glucose regulation and lipid profiles. Fasting blood glucose and hemoglobin A1c (HbA1c) tests identify undiagnosed prediabetes or frank type 2 diabetes. Standard lipid panels, which measure total cholesterol, high-density lipoprotein (HDL), LDL, and triglycerides, help quantify atherosclerotic risk. Identifying and managing metabolic abnormalities protects both long-term cardiovascular health and microvascular erectile function.

To review how clinicians structure hormone evaluations, explore our detailed resource on comprehensive hormone biomarker testing.

How Do Sleep, Mental Health, and Relational Factors Interact?

Erectile capacity is not governed solely by mechanical and chemical systems. Sleep quality, emotional state, and relationship dynamics exert profound effects on sexual function. The division between physical and psychological erectile dysfunction is often an oversimplification. In clinical practice, organic physical factors and psychological responses frequently reinforce one another.

Sleep Disruption and Obstructive Sleep Apnea

During healthy rapid eye movement (REM) sleep, men naturally experience several spontaneous nocturnal erections lasting 20 to 40 minutes each. These nocturnal tumescence events deliver oxygenated blood to the erectile tissue, supporting cellular health.

Obstructive sleep apnea (OSA) is characterized by recurrent upper airway collapse during sleep, leading to intermittent hypoxemia, fragmented sleep architecture, and autonomic stress. Systematic reviews and meta-analyses have documented a significant association between OSA and erectile dysfunction. Chronic sleep fragmentation suppresses the nocturnal testosterone surge, promotes systemic inflammation, and causes daytime fatigue, all of which diminish sexual interest and physical performance.

Psychological Mechanisms and Performance Anxiety

Psychological factors can initiate erectile difficulties independently or arise as a secondary reaction to an initial physical failure:

  • Performance anxiety: An initial episode of erectile difficulty caused by fatigue, alcohol, or stress can trigger anticipatory worry during subsequent sexual encounters. This anxiety stimulates sympathetic nervous system activity, causing a surge of adrenaline and noradrenaline. High adrenaline levels constrict penile arterioles and contract cavernous smooth muscle, directly preventing an erection.
  • Depression and chronic stress: Clinical depression alters central neurotransmitter balances, particularly dopamine and serotonin, blunting the capacity for sexual arousal. Chronic work or financial stress elevates cortisol levels and maintains a state of chronic sympathetic activation.
  • Cognitive distraction: During sexual intimacy, a man experiencing anxiety may become an observer of his own performance (often termed "spectatoring") rather than engaging with physical sensations, breaking the neurological loop needed for arousal.

Relationship Factors and Situational Variability

Relationship dynamics play an influential role in sexual function. Unresolved interpersonal conflicts, communication breakdowns, mismatched sexual desire, or partner sexual difficulties (such as dyspareunia) can inhibit natural erectile responses.

When erectile difficulties occur exclusively with a specific partner or under specific conditions, but spontaneous morning erections and normal rigidity during masturbation remain intact, psychological and contextual factors often play a central role. However, these patterns should serve as diagnostic clues rather than definitive proof, as mild vascular or neurological conditions can also manifest initially during partnered intimacy.

How Do Clinicians Evaluate Persistent Erectile Difficulties?

A structured clinical evaluation avoids unnecessary diagnostic testing while identifying treatable underlying conditions. Rather than merely writing a prescription, a physician or urologist follows a comprehensive diagnostic pathway.

Step 1: Detailed Medical, Sexual, and Psychosocial History

The clinical history forms the cornerstone of the evaluation. The physician will typically investigate:

  1. Symptom characteristics: The timeline of onset (abrupt versus gradual), symptom duration, consistency, and whether difficulties involve initiation, maintenance, or both.
  2. Context and rigidity: The presence of spontaneous morning erections, erectile quality during masturbation, and variations between different sexual situations.
  3. Associated sexual symptoms: Concurrent changes in libido, penile sensation, ejaculatory latency, orgasm quality, or penile curvature.
  4. General medical background: Diagnoses of hypertension, coronary disease, peripheral vascular disease, diabetes, dyslipidemia, neurological conditions, or sleep disorders.
  5. Surgical and trauma history: Prior pelvic surgery, prostate procedures, radiation therapy, or pelvic/perineal trauma.
  6. Medication and lifestyle history: Comprehensive review of prescribed medications, over-the-counter supplements, alcohol intake, recreational drug use, and smoking habits.
  7. Psychosocial context: Assessment of life stressors, mood disturbances, relationship satisfaction, and partner dynamics.

Step 2: Physical Examination

A targeted physical examination evaluates vascular, neurological, and genital health:

  • Genital inspection: Examination of the penis to detect fibrous plaques, abnormal curvature, or phimosis. Testicular size and consistency are evaluated to check for signs of hypogonadism.
  • Secondary sexual characteristics: Assessment of body hair distribution, muscle mass, and the presence of gynecomastia.
  • Vascular assessment: Palpation of femoral and pedal pulses, along with blood pressure measurement, to detect peripheral arterial disease.
  • Neurological screening: Assessment of perineal sensation and the bulbocavernosus reflex to evaluate sacral spinal cord integrity.

Step 3: Focused Laboratory Testing

Baseline laboratory investigations are ordered selectively based on clinical history and guideline recommendations:

  • Morning total testosterone: Drawn between 7:00 AM and 11:00 AM in a fasting state to capture peak diurnal levels. If levels are low or borderline, repeat testing along with free testosterone, LH, and prolactin is indicated.
  • Metabolic testing: Fasting blood glucose or HbA1c, combined with a comprehensive fasting lipid profile, to assess cardiometabolic health if not evaluated within the previous 12 months.
  • Targeted tests: Thyroid-stimulating hormone (TSH), serum creatinine, liver enzymes, or prostate-specific antigen (PSA) when clinically indicated by symptoms or patient age.

Step 4: Specialized Diagnostic Testing (Selected Cases)

Specialized diagnostic testing is not required for every patient. Guidelines from the AUA and EAU recommend advanced testing primarily for men with complex pelvic trauma, suspected anatomical anomalies, severe Peyronie disease, or young men being considered for vascular reconstructive surgery.

  • Penile Duplex Doppler Ultrasound (PDDU): This test evaluates blood flow dynamics within the cavernous arteries before and after the injection of a vasoactive agent into the erectile tissue. It measures peak systolic velocity (to assess arterial inflow) and end-diastolic velocity (to assess veno-occlusive function).
  • Nocturnal Penile Tumescence (NPT) Monitoring: Electronic devices worn on the penis overnight record the frequency, duration, and rigidity of nocturnal erections. While historically used to differentiate physical from psychological ED, clinical guidelines note that NPT results can be inconclusive and rarely change initial management pathways.
  • Penile Biothesiometry and Neurological Testing: Specialized sensory testing to measure vibratory perception thresholds along the penile shaft, used primarily in research settings or complex neurological workups.

If you are currently exploring potential causes of your symptoms, our resource on identifying causes of low testosterone outlines how clinicians distinguish endocrine factors from other systemic issues.

What Does the Quality of Evidence Tell Us About ED Management?

Navigating medical information regarding erectile function requires distinguishing between established clinical consensus, observational associations, and emerging research.

Established Clinical Guidance

Major medical societies, including the American Urological Association and the European Association of Urology, provide robust, evidence-based recommendations derived from systematic reviews and randomized controlled trials:

  • Structured clinical evaluations prioritizing history, physical examination, and cardiovascular risk stratification are universally recommended.
  • Morning testosterone testing is an established standard of care for men presenting with persistent erectile dysfunction.
  • First-line medical therapies, such as oral phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil, avanafil), have well-documented safety and efficacy profiles across diverse patient populations.
  • Lifestyle modifications, including aerobic exercise, dietary improvements, smoking cessation, and weight management, provide clear benefits for vascular and erectile health.

Observational and Epidemiological Evidence

Much of our understanding regarding the prevalence and natural history of erectile dysfunction stems from large observational studies:

  • The Massachusetts Male Aging Study (MMAS) provided foundational data on non-institutionalized men aged 40 to 70 in the Boston area. The study reported a combined prevalence of minimal, moderate, and complete erectile dysfunction of 52%, with complete ED rising from 5% to 15% between ages 40 and 70. While historically vital, these figures represent a specific geographic and chronological cohort and should not be interpreted as a fixed universal certainty for every aging man.
  • Epidemiological studies examining obstructive sleep apnea demonstrate a clear statistical association with erectile dysfunction. However, observational data cannot confirm that treating sleep apnea will consistently reverse erectile difficulties in an individual patient.

Emerging and Investigational Therapies

A variety of novel treatments continue to undergo scientific investigation:

  • Low-intensity extracorporeal shockwave therapy (Li-ESWT): Aims to stimulate local angiogenesis and improve microvascular perfusion. While clinical trials show promise for mild vasculogenic ED, professional guidelines currently consider the evidence heterogeneous, requiring standardized protocols before widespread clinical adoption.
  • Platelet-rich plasma (PRP) and stem cell injections: These therapies are promoted to regenerate cavernous tissue. Major urological guidelines currently classify them as experimental, citing a lack of high-quality, sham-controlled human trials verifying their safety and efficacy.

For additional perspectives on sexual health and physical vitality, explore our collection of male sexual performance resources.

What Questions Should You Discuss With Your Doctor?

Preparing specific, structured questions helps make your clinical consultation productive and thorough. Use the following framework to guide your discussion with a primary care physician or urologist:

  1. Evaluation and Causes: "Based on my medical history, symptoms, and lifestyle, which physical, hormonal, or lifestyle factors are most likely contributing to my erectile difficulties?"
  2. Cardiovascular Risk: "Could my sexual symptoms indicate underlying vascular or metabolic changes that warrant a broader cardiovascular assessment?"
  3. Medication Review: "Could any of my current prescription medications, over-the-counter supplements, or dosages be contributing to my erectile concerns? Are there alternative treatments available?"
  4. Hormone Testing: "Do my symptoms warrant a morning total and free testosterone blood test, or any additional endocrine testing?"
  5. Therapeutic Options: "What are the first-line treatment approaches appropriate for my specific health profile, and what are their expected benefits and potential side effects?"
  6. Lifestyle Adjustments: "What specific modifications to my diet, physical activity, sleep hygiene, or stress management could support my overall vascular and erectile health?"
  7. Specialist Referrals: "Would I benefit from a referral to a urologist, a cardiologist, a sleep specialist, or a qualified sex therapist to address specific aspects of my symptoms?"

Frequently Asked Questions

Can erectile dysfunction occur if testosterone levels are completely normal?

Yes. The vast majority of men with erectile dysfunction have normal testosterone levels. Erections rely primarily on vascular smooth muscle relaxation and intact neurological pathways. Vascular disease, hypertension, endothelial dysfunction, medications, and performance anxiety can cause erectile difficulties regardless of circulating hormone concentrations.

Does having morning erections mean the problem is entirely psychological?

Not necessarily. The presence of spontaneous morning or nocturnal erections indicates that the basic neurological and vascular mechanisms are functional. However, it does not completely rule out physical factors. Early or mild vascular disease may permit erections during restful sleep when sympathetic tone is low, but fail during the higher physical and autonomic demands of partnered intimacy.

How quickly does erectile function improve after starting lifestyle changes?

Vascular endothelial health and nitric oxide production typically respond gradually to lifestyle modifications. Studies evaluating structured aerobic exercise, Mediterranean-style dietary patterns, and weight reduction show measurable improvements in erectile quality over three to six months. Consistency in cardiovascular exercise, smoking cessation, and blood pressure control produces the most reliable long-term benefits.

Is specialized penile ultrasound necessary for everyone with erectile dysfunction?

No. Penile duplex Doppler ultrasound is a specialized diagnostic test reserved for specific clinical situations. Guidelines recommend ultrasound primarily when initial medical treatments fail, when pelvic trauma or structural Peyronie disease is present, or when a patient is being evaluated for potential vascular reconstructive surgery. Most men achieve an accurate assessment through a standard medical history, physical examination, and basic laboratory panel.

Sources

  1. A. Salonia (Chair), L. Boeri, P. Capogrosso, G. Corona,
  2. The Princeton IV Consensus Recommendations for ...
  3. Erectile Dysfunction: AUA Guideline
  4. Princeton IV consensus guidelines: PDE5 inhibitors and ...
  5. EAU Sexual and Reproductive Health Guideline Summary
  6. Erectile Dysfunction - Urology - Merck Manual Professional ...
  7. Medications
  8. Association between obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis - International Journal of Impotence Research
  9. Erectile dysfunction and cardiovascular disease - PMC
  10. EAU Guidelines on Sexual and Reproductive Health - Uroweb
  11. Erectile Dysfunction: AUA Guideline (2018)-guideline)
  12. (PDF) ERECTILE DYSFUNCTION: AUA GUIDELINE

Testostra explains testosterone biology, testing, symptoms, lifestyle factors and TRT with careful sourcing and clear clinical limits.

FacebookInstagramYouTubeX (Twitter)Pinterest

Recent resources

Man walking outdoors after exercise in a green urban setting.
GET IN TOUCH

Have a testosterone question or research topic in mind?

Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.

Contact Testostra